The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 05, 2020

Filed:

Jul. 25, 2018
Applicant:

Yeda Research and Development Co. Ltd., Rehovot, IL;

Inventors:

Yosef Yarden, Rehovot, IL;

Silvia Carvalho, Rehovot, IL;

Moshit Lindzen, Rehovot, IL;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/22 (2006.01); A61K 39/00 (2006.01); A61K 31/704 (2006.01); A61K 33/24 (2019.01); G01N 33/574 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
C07K 16/22 (2013.01); A61K 31/704 (2013.01); A61K 33/24 (2013.01); A61K 45/06 (2013.01); G01N 33/57407 (2013.01); G01N 33/57449 (2013.01); A61K 2039/505 (2013.01); C07K 2317/24 (2013.01); C07K 2317/565 (2013.01); G01N 33/57438 (2013.01); G01N 2333/485 (2013.01); G01N 2333/495 (2013.01); G01N 2800/52 (2013.01);
Abstract

A method of determining the suitability of a subject to a treatment with an anti-amphiregulin antibody, wherein the subject has a cancer selected from the group consisting of ovarian cancer, head and neck cancer and pancreatic cancer exhibiting resistance to chemotherapy, is provided. The method comprising analyzing in a biological sample of the subject expression level of amphiregulin, transforming growth factor alpha (TGF-alpha) and heparin-binding epidermal growth factor (HB-EGF), wherein a level of expression of the amphiregulin above a predetermined threshold and no expression of the TGF-alpha and/or the HB-EGF or an expression below a predetermined level of the TGF-alpha and/or the HB-EGF is indicative of the suitability of the subject to treatment with the anti-amphiregulin antibody. Methods for treating cancer are also provided, as well as antibodies and pharmaceutical compositions.


Find Patent Forward Citations

Loading…